News Results

There are 987,645 News Results

Oct 7, 2025
Edmentum Names Brad Baumgartner First Chief Government Affairs Officer
Baumgartner, the former CEO of MetaMetrics and BookNook, will lead Edmentum's efforts to strengthen state-level alignment nationwide
Oct 7, 2025
Rural Wisconsin School Districts Collaborate to Expand Mental Health Support for K12 Students
Student mental health leader Uwill provides immediate teletherapy support for K12 students in Abbotsford and Colby School Districts, addressing growing demand
Oct 8, 2025
Seattle Children's appoints Dr. Christopher Longhurst as chief executive officer
SEATTLE, Oct. 8, 2025 /PRNewswire/ -- Seattle Children's today announced the appointment of Dr. Christopher Longhurst as its next chief executive officer, effective Jan. 5, 2026. The Seattle Children's Hospital...
Oct 9, 2025
Dr. Jason S. Frischer named Surgeon-in-Chief and Chief of Pediatric Surgery at Le Bonheur Children's and UT Health Science Center
MEMPHIS, Tenn., Oct. 9, 2025 /PRNewswire/ -- Le Bonheur Children's Hospital and the University of Tennessee Health Science Center (UTHSC) are proud to announce the appointment of Jason S. Frischer,...
Oct 9, 2025
Rajant Launches Next-Generation BC Commander Suite for Streamlined Monitoring and Management
Rajant Corporation today introduced the next evolution of its BreadCrumb® (BC) Commander Suite, now featuring new Advanced and Enterprise subscription tiers in addition to the existing Core tier. This expanded...
Jun 12, 2017
Axovant Sciences Announces Fiscal Year-End Financial Results and Corporate Updates
BASEL, Switzerland, June 13, 2017 /PRNewswire/ -- Axovant Sciences (NYSE: AXON), today reported financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2017, as well...
Mar 7, 2018
Audentes Therapeutics Reports Fourth Quarter 2017 and Full Year Financial Results and Provides Corporate Update
Audentes Therapeutics Reports Fourth Quarter 2017 and Full Year Financial Results and Provides Corporate Update
Jul 16, 2018
Phase 3 CREDENCE Renal Outcomes Trial of INVOKANA® (canagliflozin) is Being Stopped Early for Positive Efficacy Findings
RARITAN, N.J., July 16, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Phase 3 CREDENCE (
98765

Pages

1

Stories of the day

Oct 9, 2025
Helsing acquires Blue Ocean, a specialist in autonomous underwater vehicles, to...
Oct 9, 2025
Viasat Awarded Contract by U.S. Space Force for Protected Tactical SATCOM-...
Oct 9, 2025
US Army Selects L3Harris to Support NGC2 Program
Oct 9, 2025
Damen Naval signs contract with Terma A/S for Decoy Launching System on...